Hostname: page-component-cd9895bd7-dzt6s Total loading time: 0 Render date: 2024-12-18T07:45:41.525Z Has data issue: false hasContentIssue false

Anti-emetic efficacy of prophylactic granisetron compared with perphenazine for the prevention of post-operative vomiting in children

Published online by Cambridge University Press:  16 August 2006

Y. Fujii
Affiliation:
Department of Anaesthesiology, University of Tsukuba Institute of Clinical Medicine, Tsukuba City, Ibaraki, Japan
Y. Saitoh
Affiliation:
Department of Anaesthesiology, Toride Kyodo General Hospital, Toride City, Ibaraki, Japan
H. Tanaka
Affiliation:
Department of Anaesthesiology, Toride Kyodo General Hospital, Toride City, Ibaraki, Japan
H. Toyooka
Affiliation:
Department of Anaesthesiology, University of Tsukuba Institute of Clinical Medicine, Tsukuba City, Ibaraki, Japan
Get access

Abstract

We have compared the efficacy of granisetron with perphenazine in the prevention of vomiting after tonsillectomy with or without adenoidectomy in children. In a prospective, randomized, double-blind study, 90 paediatric patients, ASA I, aged 4–10 years, received granisetron 40 mg kg−1 or perphenazine 70 mg kg−1 (n=45 each) intravenously immediately after an inhalation induction of anaesthesia. A standard general anaesthetic technique was employed throughout. A complete response, defined as no emesis with no need for another rescue antiemetic, during the first 3 h (0–3 h) after anaesthesia was 87% with granisetron and 78% with perphenazine (P=0.204). The corresponding incidence during the next 21 h (3–24 h) after anaesthesia was 87% and 62% (P=0.007). No clinically serious adverse events were observed in any of the groups. We conclude that granisetron is a better anti-emetic than perphenazine for the long-term prevention of post-operative vomiting in children undergoing general anaesthesia for tonsillectomy.

Type
Original Article
Copyright
1999 European Society of Anaesthesiology

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)